C
EW icon

Certuity’s Edwards Lifesciences EW Stock Holding History

Certuity’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,400
Closed -$186K – 194
2019
Q4 		$186K Buy
+2,400
New +$187K 0.09% 169

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Certuity's EW Position: Q2 2026 in Review

Certuity increased its Edwards Lifesciences (EW) stake by 37% in Q2 2026, buying an estimated $99.8K and bringing the position to 4,438 shares worth $401K. The position accounts for 0.02% of the portfolio, ranked #418.

Certuity first reported a position in EW in Q4 2019 and has held it in 15 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Certuity held 4,438 shares of Edwards Lifesciences worth $401K as of Q2 2026.
  • Certuity bought 1,191 Edwards Lifesciences shares in Q2 2026, an estimated $99.8K.
  • Edwards Lifesciences made up 0.02% of Certuity's portfolio in Q2 2026, its #418 holding.
  • Certuity first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 15 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.